| Bortezomib - Wikipedia, the free encyclopedia Bortezomib (INN, originally codenamed PS-341 ; marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. Read More |
| Bortezomib - Proteasome inhibitor for cancer Proteasome inhibitor drug for treating cancer. ... Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome. Read More |
| VELCADE® (bortezomib) | FDA Approved Subcutaneous Administration VELCADE ® (bortezomib) has received FDA Approval for subcutaneous administration Ask your doctor about VELCADE. Read More |
| Bortezomib - National Cancer Institute - Comprehensive Cancer ... This page contains brief information about bortezomib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ... Read More |
| Bortezomib, Velcade - Chemotherapy Drugs, Chemo Drug Side Effects Bortezomib is the generic name for Velcade. Bortezomib is a targeted therapy classified as a proteasome inhibitor. Read More |
| Bortezomib: MedlinePlus Drug Information - National Library of ... Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other ... Read More |
| Bortezomib - PubMed Health - National Center for Biotechnology ... Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other ... Read More |
| Bortezomib Facts and Comparisons at Drugs.com All about Bortezomib. View complete and up to date Bortezomib information - part of the Drugs.com trusted medication database. Read More |
| Bortezomib (Velcade) | Proteasome Inhibitor | Buy Bortezomib ... Bortezomib also known as Velcade, MG-341, PS-341 is proteasome Inhibitor, effectively inhibits proteasome activity (Ki-0.6 nM). Order Bortezomib (Velcade) from ... Read More |
| Complete Bortezomib information from Drugs.com Bortezomib professional patient advice. Specific and up to date information about Bortezomib. Read More |
